{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T04:18:08Z","timestamp":1782620288933,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T00:00:00Z","timestamp":1658102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T00:00:00Z","timestamp":1658102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81700776"],"award-info":[{"award-number":["81700776"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s12072-022-10387-8","type":"journal-article","created":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T11:02:51Z","timestamp":1658142171000},"page":"1424-1434","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Effects of serum branched-chain amino acids on nonalcoholic fatty liver disease and subsequent cardiovascular disease"],"prefix":"10.1007","volume":"16","author":[{"given":"Fei","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linghui","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hairong","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanwen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,18]]},"reference":[{"issue":"1","key":"10387_CR1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/CM9.0000000000001263","volume":"134","author":"YX Xian","year":"2020","unstructured":"Xian YX, Weng JP, Xu F. MAFLD vs. NAFLD: shared features and potential changes in epidemiology, pathophysiology, diagnosis, and pharmacotherapy. Chin Med J (Engl). 2020;134(1):8\u201319. https:\/\/doi.org\/10.1097\/CM9.0000000000001263","journal-title":"Chin Med J (Engl)"},{"issue":"11","key":"10387_CR2","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s00535-021-01796-x","volume":"56","author":"K Tokushige","year":"2021","unstructured":"Tokushige K, Ikejima K, Ono M, et al. Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis 2020. J Gastroenterol. 2021;56(11):951\u2013963. https:\/\/doi.org\/10.1007\/s00535-021-01796-x","journal-title":"J Gastroenterol"},{"issue":"5","key":"10387_CR3","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/dom.14322","volume":"23","author":"B Cariou","year":"2021","unstructured":"Cariou B, Byrne CD, Loomba R, Sanyal AJ. Nonalcoholic fatty liver disease as a metabolic disease in humans: a literature review. Diabetes Obes Metab. 2021;23(5):1069\u20131083. https:\/\/doi.org\/10.1111\/dom.14322","journal-title":"Diabetes Obes Metab"},{"issue":"20","key":"10387_CR4","doi-asserted-by":"publisher","first-page":"4688","DOI":"10.12998\/wjcc.v8.i20.4688","volume":"8","author":"U Arslan","year":"2020","unstructured":"Arslan U, Yener\u00e7a\u011f M. Relationship between non-alcoholic fatty liver disease and coronary heart disease. World J Clin Cases. 2020;8(20):4688\u20134699. https:\/\/doi.org\/10.12998\/wjcc.v8.i20.4688","journal-title":"World J Clin Cases"},{"issue":"9","key":"10387_CR5","doi-asserted-by":"publisher","first-page":"4459","DOI":"10.3390\/ijms22094459","volume":"22","author":"SA Dabravolski","year":"2021","unstructured":"Dabravolski SA, Bezsonov EE, Baig MS, et al. Mitochondrial mutations and genetic factors determining NAFLD risk. Int J Mol Sci. 2021;22(9):4459. https:\/\/doi.org\/10.3390\/ijms22094459","journal-title":"Int J Mol Sci"},{"key":"10387_CR6","doi-asserted-by":"publisher","first-page":"3920196","DOI":"10.1155\/2020\/3920196","volume":"2020","author":"DM Tanase","year":"2020","unstructured":"Tanase DM, Gosav EM, Costea CF, et al. The intricate relationship between type 2 diabetes mellitus (T2DM), insulin resistance (IR), and nonalcoholic fatty liver disease (NAFLD). J Diabetes Res. 2020;2020:3920196. https:\/\/doi.org\/10.1155\/2020\/3920196","journal-title":"J Diabetes Res"},{"issue":"36","key":"10387_CR7","doi-asserted-by":"publisher","first-page":"6549","DOI":"10.3748\/wjg.v23.i36.6549","volume":"23","author":"S Singh","year":"2017","unstructured":"Singh S, Osna NA, Kharbanda KK. Treatment options for alcoholic and non-alcoholic fatty liver disease: a review. World J Gastroenterol. 2017;23(36):6549\u20136570. https:\/\/doi.org\/10.3748\/wjg.v23.i36.6549","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10387_CR8","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00726-014-1894-9","volume":"47","author":"AD Lake","year":"2015","unstructured":"Lake AD, Novak P, Shipkova P, et al. Branched chain amino acid metabolism profiles in progressive human nonalcoholic fatty liver disease. Amino Acids. 2015;47(3):603\u2013615. https:\/\/doi.org\/10.1007\/s00726-014-1894-9","journal-title":"Amino Acids"},{"issue":"3","key":"10387_CR9","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3803\/EnM.2019.34.3.234","volume":"34","author":"MAB Siddik","year":"2019","unstructured":"Siddik MAB, Shin AC. Recent progress on branched-chain amino acids in obesity, diabetes, and beyond. Endocrinol Metab (Seoul). 2019;34(3):234\u2013246. https:\/\/doi.org\/10.3803\/EnM.2019.34.3.234","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"2","key":"10387_CR10","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00125-011-2356-5","volume":"55","author":"SH Shah","year":"2012","unstructured":"Shah SH, Crosslin DR, Haynes CS, et al. Branched-chain amino acid levels are associated with improvement in insulin resistance with weight loss. Diabetologia. 2012;55(2):321\u2013330. https:\/\/doi.org\/10.1007\/s00125-011-2356-5","journal-title":"Diabetologia"},{"issue":"4","key":"10387_CR11","doi-asserted-by":"publisher","first-page":"954","DOI":"10.3390\/ijms19040954","volume":"19","author":"C Nie","year":"2018","unstructured":"Nie C, He T, Zhang W, Zhang G, Ma X. Branched chain amino acids: beyond nutrition metabolism. Int J Mol Sci. 2018;19(4):954. https:\/\/doi.org\/10.3390\/ijms19040954","journal-title":"Int J Mol Sci."},{"issue":"7","key":"10387_CR12","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3390\/nu8070405","volume":"8","author":"MS Yoon","year":"2016","unstructured":"Yoon MS. The emerging role of branched-chain amino acids in insulin resistance and metabolism. Nutrients. 2016;8(7):405. https:\/\/doi.org\/10.3390\/nu8070405","journal-title":"Nutrients"},{"issue":"1","key":"10387_CR13","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1080\/07853890.2021.1965204","volume":"53","author":"W Hu","year":"2021","unstructured":"Hu W, Liu Z, Yu W, et al. Effects of PPM1K rs1440581 and rs7678928 on serum branched-chain amino acid levels and risk of cardiovascular disease. Ann Med. 2021;53(1):1316\u20131326. https:\/\/doi.org\/10.1080\/07853890.2021.1965204","journal-title":"Ann Med"},{"key":"10387_CR14","doi-asserted-by":"publisher","first-page":"8173905","DOI":"10.1155\/2016\/8173905","volume":"2016","author":"W Hu","year":"2016","unstructured":"Hu W, Sun L, Gong Y, et al. Relationship between branched-chain amino acids, metabolic syndrome, and cardiovascular risk profile in a Chinese population: a cross-sectional study. Int J Endocrinol. 2016;2016:8173905. https:\/\/doi.org\/10.1155\/2016\/8173905","journal-title":"Int J Endocrinol"},{"issue":"4","key":"10387_CR15","doi-asserted-by":"publisher","first-page":"537","DOI":"10.2337\/diacare.20.4.537","volume":"20","author":"XR Pan","year":"1997","unstructured":"Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20(4):537\u2013544. https:\/\/doi.org\/10.2337\/diacare.20.4.537","journal-title":"Diabetes Care"},{"issue":"1","key":"10387_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0170758","volume":"12","author":"W Hu","year":"2017","unstructured":"Hu W, Shao X, Guo D, et al. Relationship of serum betatrophin with nonalcoholic fatty liver in a Chinese population. PLoS One. 2017;12(1): e0170758. https:\/\/doi.org\/10.1371\/journal.pone.0170758","journal-title":"PLoS One"},{"issue":"9","key":"10387_CR17","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate [published correction appears in Ann Intern Med. 2011 Sep 20;155(6):408]. Ann Intern Med. 2009;150(9):604\u2013612. https:\/\/doi.org\/10.7326\/0003-4819-150-9-200905050-00006","journal-title":"Ann Intern Med"},{"issue":"5","key":"10387_CR18","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1177\/2047487315587402","volume":"23","author":"KF Zhu","year":"2016","unstructured":"Zhu KF, Wang YM, Zhu JZ, Zhou QY, Wang NF. National prevalence of coronary heart disease and its relationship with human development index: a systematic review. Eur J Prev Cardiol. 2016;23(5):530\u2013543. https:\/\/doi.org\/10.1177\/2047487315587402","journal-title":"Eur J Prev Cardiol"},{"key":"10387_CR19","doi-asserted-by":"publisher","first-page":"170","DOI":"10.12688\/f1000research.12028.1","volume":"7","author":"S Faasse","year":"2018","unstructured":"Faasse S, Braun H, Vos M. The role of NAFLD in cardiometabolic disease: an update. F1000Res. 2018;7:170. https:\/\/doi.org\/10.12688\/f1000research.12028.1","journal-title":"F1000Res"},{"key":"10387_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.101143","volume":"50","author":"KK Bence","year":"2021","unstructured":"Bence KK, Birnbaum MJ. Metabolic drivers of non-alcoholic fatty liver disease. Mol Metab. 2021;50: 101143. https:\/\/doi.org\/10.1016\/j.molmet.2020.101143","journal-title":"Mol Metab"},{"issue":"7","key":"10387_CR21","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","volume":"158","author":"TG Cotter","year":"2020","unstructured":"Cotter TG, Rinella M. Nonalcoholic fatty liver disease 2020: the state of the disease. Gastroenterology. 2020;158(7):1851\u20131864. https:\/\/doi.org\/10.1053\/j.gastro.2020.01.052","journal-title":"Gastroenterology"},{"issue":"7","key":"10387_CR22","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.numecd.2016.03.013","volume":"26","author":"S Haufe","year":"2016","unstructured":"Haufe S, Witt H, Engeli S, et al. Branched-chain and aromatic amino acids, insulin resistance and liver specific ectopic fat storage in overweight to obese subjects. Nutr Metab Cardiovasc Dis. 2016;26(7):637\u2013642. https:\/\/doi.org\/10.1016\/j.numecd.2016.03.013","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"7","key":"10387_CR23","doi-asserted-by":"publisher","first-page":"642","DOI":"10.3390\/nu9070642","volume":"9","author":"M Goffredo","year":"2017","unstructured":"Goffredo M, Santoro N, Tric\u00f2 D, et al. A branched-chain amino acid-related metabolic signature characterizes obese adolescents with non-alcoholic fatty liver disease. Nutrients. 2017;9(7):642. https:\/\/doi.org\/10.3390\/nu9070642","journal-title":"Nutrients"},{"issue":"5","key":"10387_CR24","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1159\/000343204","volume":"5","author":"S Wahl","year":"2012","unstructured":"Wahl S, Yu Z, Kleber M, et al. Childhood obesity is associated with changes in the serum metabolite profile. Obes Facts. 2012;5(5):660\u2013670. https:\/\/doi.org\/10.1159\/000343204","journal-title":"Obes Facts"},{"issue":"8","key":"10387_CR25","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1053\/j.gastro.2016.03.009","volume":"150","author":"V Nobili","year":"2016","unstructured":"Nobili V, Alisi A, Newton KP, Schwimmer JB. Comparison of the phenotype and approach to pediatric vs adult patients with nonalcoholic fatty liver disease. Gastroenterology. 2016;150(8):1798\u20131810. https:\/\/doi.org\/10.1053\/j.gastro.2016.03.009","journal-title":"Gastroenterology"},{"key":"10387_CR26","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ebiom.2016.10.013","volume":"13","author":"F Zhang","year":"2016","unstructured":"Zhang F, Zhao S, Yan W, et al. Branched chain amino acids cause liver injury in obese\/diabetic mice by promoting adipocyte lipolysis and inhibiting hepatic autophagy. EBioMedicine. 2016;13:157\u2013167. https:\/\/doi.org\/10.1016\/j.ebiom.2016.10.013","journal-title":"EBioMedicine"},{"issue":"4","key":"10387_CR27","doi-asserted-by":"publisher","first-page":"E311","DOI":"10.1152\/ajpendo.00161.2015","volume":"309","author":"NE Sunny","year":"2015","unstructured":"Sunny NE, Kalavalapalli S, Bril F, et al. Cross-talk between branched-chain amino acids and hepatic mitochondria is compromised in nonalcoholic fatty liver disease. Am J Physiol Endocrinol Metab. 2015;309(4):E311\u2013E319. https:\/\/doi.org\/10.1152\/ajpendo.00161.2015","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10387_CR28","doi-asserted-by":"publisher","first-page":"551758","DOI":"10.3389\/fimmu.2020.551758","volume":"11","author":"BL Zaric","year":"2020","unstructured":"Zaric BL, Radovanovic JN, Gluvic Z, et al. Atherosclerosis linked to aberrant amino acid metabolism and immunosuppressive amino acid catabolizing enzymes. Front Immunol. 2020;11:551758. https:\/\/doi.org\/10.3389\/fimmu.2020.551758","journal-title":"Front Immunol"},{"issue":"2","key":"10387_CR29","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1093\/cvr\/cvr070","volume":"90","author":"Y Huang","year":"2011","unstructured":"Huang Y, Zhou M, Sun H, Wang Y. Branched-chain amino acid metabolism in heart disease: an epiphenomenon or a real culprit? Cardiovasc Res. 2011;90(2):220\u2013223. https:\/\/doi.org\/10.1093\/cvr\/cvr070","journal-title":"Cardiovasc Res"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-022-10387-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-022-10387-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-022-10387-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,27]],"date-time":"2022-11-27T01:39:01Z","timestamp":1669513141000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-022-10387-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,18]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["10387"],"URL":"https:\/\/doi.org\/10.1007\/s12072-022-10387-8","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,18]]},"assertion":[{"value":"4 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Fei Guo, Rui Chen, Linghui Kong, Pan Wei, Ziyu Liu, Xiaoqing Wang, Hairong Hao, Yanwen Lu, and Wen Hu declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Huai'an Second Hospital Ethics Committee of the Xuzhou Medical University School of Medicine and registered with ChiCTR-TRC-14005029.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All participants provided written informed consent before enrollment.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"This manuscript is approved by all authors for publication.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}